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March 8, 1990 Abstract- Many organic Cat+-channel antagonists (OCA), including verapamil, diltiazem and nicardipine, have been shown to inhibit single indirect twitch responses at 50-100 uM and to cause tetanic fade at 10-30 uM by a mech anism unrelated to their effects on Ca2+ channels but rather to an inhibition of the Na+-channels of preterminal axons (1, 2). Nifedipine is an exception in this respect be cause axonal conductions (3) as well as neuromuscular transmissions in the mouse and frog muscles are not blocked at 100 uM (1, 4, 5) . Moreover, unlike other antagonists, nifedipine enhances the neuromuscular trans mission blocked by tubocurarine or by low Ca2+ media (2). On the other hand, the potencies of various neuromuscular blocking agents have been shown to be markedly enhanced by OCA at concentrations (1-10 tM) which by them selves do not affect endplate responses evoked by neurally released acetylcholine (ACh) (1, 2, 6). For example, the median effective concentration (IC50) of succinyl choline (SCh), an agonist-type depolarizing agent, to block endplate current in frog muscles was lowered 7.7 and 31 -fold, re spectively, in the presence of 10 uM verapa mil and nicardipine, whereas nifedipine af forded no potentiation (7). In rat diaphragm preparations, the IC50 of neomycin, a presy naptically acting blocking agent, was lowered 185-, 94 and 7-fold, respectively, when pretreated with 10 !iM each of nifedipine, verapamil and diltiazem (8). A possible poten tiation of antidepolarizing neuromuscular blocking agents has been also implicated in various animals (8-13). The interactions of OCA with these different groups of neuro muscular blocking agents, however, were not compared, and it remains to be answered whether OCA potentiate all neuromuscular blocking agents indiscriminately and whether the same or different mechanisms are in volved in these synergistic interactions, if any. In the present experiments, the effects of subparalytic concentrations of Mn2+, neomy cin and OCA (verapmil, diltiazem, nicardipine and nifedipine) against the neuromuscular blocking actions of tubocurarine, SCh, de camethonium and neomycin were compared in the isolated mouse phrenic nerve-dia phragm preparations.
It was found that only the neuromuscular blocking effect of SCh and decamethonium was markedly potentiated by OCA. No significant synergism other than simple addition was found among other com binations of drugs. This unique synergism by OCA appears to be due to an enhancement of desensitization of postsynaptic ACh receptors induced by the agonist-type depolarizing agents.
Materials and Methods

Twitch
responses: Phrenic nerve-dia phragm preparations (14) isolated from ICR mice (20-25 g) were bathed in 20 ml Tyrode solution (137 mM NaCI, 2.8 mM KCI, 1.8 mM CaC12, 1.1 MM MgC12, 0.33 mM NaH2PO4, 11.9 mM NaHCO3 and 11.2 mM glucose) oxygenated with 95% 02+5% CO2 and main tained at 37±0.5'C. A resting tension of 0.5 g was applied. Indirect twitch responses of the diaphragm were evoked by stimulation of the phrenic nerve at 0.2 Hz with supramaximal rectangular pulses of 0.05 msec width and recorded isometrically with a transducer (Gould BG 25) on a recorder (Gould 2200S).
The potencies of each drug in blocking neuromuscular transmission were compared by the concentrations of drugs that depressed the amplitude of indirect twitch responses by 50% in the absence or presence of interacting agents. These concentratins (IC50) were ob tained by interpolation from the concentra tion-inhibition curves constructed by the degree of inhibition of inditect twitch re sponses displayed by at least four concen trations of each blocking agent.
Intracellular recordings: The organ bath contained 15 ml Tyrode solution maintained at 36±0.5'C. Transmembrane potentials were measured by inserting a glass microelectrode filled with 3 M KCI (electrode resistances 5 10 MQ) into the diaphragm muscles. The resting membrane potential and the miniature endplate potentials (m.e.p.p.s) were moni tored at the endplate region of intact (uncut) preparations. The resting potentials were ob tained from about 25 endplates for each prep aration before and after application of SCh. The amplitude of m.e.p.p.s were measured at about 10 endplates for each preparation.
The endplate potentials (e.p.p.s) evoked by stimulation of the phrenic nerve at 1 Hz were recorded in the cut muscle preparation (15) which was equilibrated in Tyrode solu tion for 2-2.5 hr until the resting membrane potential declined to -45 to -40 mV, and the muscle fiber became incapable of generating action potentials. The e.p.p.s and m.e.p.p.s were corrected for the nonlinear summation in order to compensate for SCh-induced de polarization according to the following equa tion assuming 0 mVfor reversal potential (16): e.p.p.=e.p.p.observed x Memb. potentialcorrected M emb. potentialobserved -0.54 x e.p.p.observed Antic holinesterase activity: The homo genate of mouse diaphragms was used as a source of cholinesterase. Mouse diaphragms were homogenized in phosphate-free Tyrode solution at 100 mg/ml and incubated with the test drugs at 37±0.2'C for 30 min. Acetylcholine was then added at 2 mM to start the enzymatic hydrolysis, which was monitored for 5 min by pH-stat titration with 0.02 N NaOH at pH 7.4 (1). The enzymic hydrolysis of ACh was corrected for the spontaneous hydrolysis as obtained in the absence of homoaenate. 
Results
Effects of OCA on neuromuscular transmis sion: As previously reported (1, 2) all OCA used in the present experiment, except nifedi pine, started to inhibit the neuromuscular transmission of normal mouse diaphragms only at 50 /iM or higher. These drugs also caused tetanic contraction to fade during re petitive stimulation at 30 pM due to an use dependent block of axon conduction. By contrast, nifedipine did not show appreciable blocking at 100 W and was even antagonis tic to the blocking effect of tubocurarine and low Cat'. At 10 pcM, all of these OCA depres sed neither the single indirect twitch re sponses nor the amplitudes of e.p.p.s and m.e.p.p.s. This concentration of OCA was thereby used for the interaction with other neuromuscular blocking agents.
Interactions with tubocurarine, SCh and neomycin: The concentrations of tubocurarine, SCh and neomycin to depress the twitch re sponse to indirect single stimulation by 50% (IC50) are listed in Table 1 . Nicardipine (10 iiM), Mn2+ (80 ppM) or neomycin (5 pM) showed no appreciable effect on indirect twitch responses in normal preparations, but caused about 20-30% depression of single twitch responses in the presence of 0.5 /iM tubocurarine which depressed the twitch re sponse by about 10%. The changes of IC50's for tubocurarine, SCh and neomycin after pretreatments with nicardipine, Mn2+ or neo mycin are compared in Table 1 . The IC50's for tubocurarine and neomycin were reduced after these pretreatments by less than 60%, suggesting that pretreatments with either nicardipine, Mn2+ or neomycin cause no significant potentiation (synergism) against the actions of tubocurarine and neomycin. Neomycin and Mn2+ pretreatments also ap peared to interact with SCh similarly as with tubocurarine and reduced the IC50 by less than 40%. In contrast to the above combina tions of drugs, pretreatment with nicardipine resulted in a 12.5-fold reduction of IC50 (from 32 to 2.6 ppM) for SCh, indicating a synergis tic interaction between nicardipine and SCh.
Interactions by other Cat+-channel an tagonists: Interactions evoked by verapamil, diltiazem and nifedipine were studied to see whether the selective potentiation of SCh by nicardipine is shared by other OCA. Both verapamil (10 ,aM) and diltiazem (10 itM), like nicardipine, enhanced neuromuscular block by Mn2+, tubocurarine or neomycin slightly by about 20%. The block by SCh, however, was markedly potentiated. Figure 1 illustrates the leftward parallel shift of the con centration-effect curves for SCh-induced in hibition of single twitch responses. The IC50 for SCh was reduced by 1 6.7-fold from 32 to 1.9 utM after diltiazem pretreatment and by 4.5-fold to 7.1 ;cM after verapamil. Nifedipine (10 tiM) antagonized, rather than enhanced, the blockade caused by tubocurarine and Mn2+, while it had no significant effect against neomycin (data not shown). Nevertheless, the block by SCh in the presence of nifedipine was enhanced by 3.1 -fold (IC50: 10 ,uM).
Effects on SCh-induced depolarization: The endplate area of surface muscle fibers of mouse diaphragms was rapidly depolarized to a peak within 1-3 min on application of SCh; and thereafter, the depolarization declined (i.e., desensitization) in 5 min by about 25% to a plateau that was maintained for more than 30 min. The plateau depolarization by SCh was dose-dependent at 0.3-3 iiM (Fig. 2 ). After application of 3 /tM SCh, the membrane potential at the endplate area was maximally depolarized from -80.8±0.9 mV to -62.9± 1.2 mV at the plateau. With nicardipine at 2 ,tiM, the depolarization by SCh was markedly reduced noncompetitively (Fig. 2) , shifting the concentration-depolarization curve to the right and reducing the maximal depolarization by about 40%. When pretreated with nicar dipine at 10 tiM, no depolarization could be effected by SCh even at a concentration as high as 30 tiM.
Fig. 2. Effects of nicardipine
on SCh-induced depolarization of the mouse diaphragm endplate. The magnitude of plateau depolarization 5-10 min after application of SCh was expressed as a percent of the maximal depolarization by SCh in the control preparations (0), which reduced the membrane potential from -80.8±0.9 mV to -62.9±1.2 mV. Nicardipine was added 30 min before SCh at 2 pM (0-0) or 10 f-tM (0---0). Mean±S.E. n>4. (Fig. 3) . At 10 ,uM of SCh, the amplitude of e.p.p.s was depressed by about 83% and the twitch response by about 10%. Considering about a 4-fold safety factor in neuromuscular transmission (17, 18), the above findings suggest that the neuromuscular block by SCh is causally related to inhibition of e.p.p.s, but not to depolarization per se in the mouse muscle (19). SCh also depressed the amplitude of m.e.p.p.s, the magnitude of inhibition being somewhat more marked than that on e.p.p. amplitudes (Fig. 3) 
Discussion
The present experiments demonstrate that the interactions between OCA and various neuromuscular blocking agents are markedly different. The interactions with depolarizing agents, e.g., SCh and decamethonium, are unique in that a synergism with marked poten tiation is evident. Nifedipine is not an excep tion in this respect despite that this dihydro pyridine analogue facilitated the neuromus cular transmission and increased the neural release of ACh (1, 2). In contrast to OCA, Mn2+ and neomycin lack this synergistic ac tivity with the action of SCh and decame thonium.
These results suggest that the mechanism of synergism with depolarizing agents, though common to all OCA, is unrelated to their on Ca2+ influx or on ACh release. This inference is further supported by the findings that combined uses of nicardipine with SCh or decamethonium did not decrease the quantal release of ACh from the motor nerve terminal, indicating that the synergism originates from an action on postsynaptic sites. On the other hand, since the twitch in response to direct stimulation of muscle was not blocked by combined uses of SCh with nicardipine, the synergism is unlikely due to an effect on the muscle fiber or T tubule (20, 21) . In accordance with the observations that endplate currents or muscle contractures evoked by bath-application of ACh are de pressed by OCA (2, 4, 6, 22, 23) , the present experiments showed that the depolarization in response to SCh or decamethonium was markedly attenuated by nicardipine. Since the responses to neurally released ACh (e.g., e.p.p.s and m.e.p.p.s) were unaffected by 10 icM nicardipine in the absence of SCh, it is likely that the ACh receptor-channel complex is made insensitive to opening by nicardipine because of the prolonged action of exogenous agonists, presumably by promoting desensiti zation. Proadifen (SKF-525A), a desensitiza tion-promoting agent, has been shown to act like OCA (24). Nerve-released ACh normally acts for no more than a few msec because of rapid hydrolysis, whereas exogenously added agonists may continue to interact with ACh receptors for many seconds to minutes. Since desensitization of nicotinic ACh receptor is enhanced as the duration of exposure to agonists is increased (25), the difference be tween the effect of OCA on neural ACh and that on exogenous agonists can be accounted for on the basis of their different action times with receptors. An enhancement of desensiti zation of nicotinic ACh receptors has been observed with OCA in skeletal muscles as well as in other organs (4, 6, 21, 26) . It may be concluded, as previously proposed for a frog muscle (7), that OCA sensitize postsynaptic ACh receptors to agonist-induced desensiti zation and thereby cause a selective synergism with the depolarizing agents.
Based on a radioligand binding study showing competitive displacement by OCA of an endplate channel probe, phencyclidine (27), one may speculate that OCA bind to a transmembrane domain of ACh channels which could be homologous to other voltage dependent ion-channels (28), and accelerate agonists-induced desensitization allosteri cally. A decreased frequency of opening events of ACh channels induced by ACh in the presence of diltiazem or verapamil (6, 23) is in support of this view.
The insignificant synergism between OCA and neomycin is in discrepancy with the marked potentiation (1 80-fold) reported in rat diaphragm preparations (8). We have re peated this experiment using rats of the same strain (Sprague-Dawley) but found that no OCA synergistically enhanced the neuromus cular block by neomycin.
A comparison of the magnitudes of syner gistic interactions of nicardipine with SCh and with decamethonium reveals that the in hibitions of e.p.p.s and m.e.p.p.s by both agonists are equally enhanced and are suf ficient to account for the sensitization to the neuromuscular blocking action of decame thonium in whole muscles. However, sensi tization to SCh-induced neuromuscular block of single twitches by nicardipine apparently far exceeds its effects on e.p.p.s. and m.e.p.p.s. This difference may be explained on the basis that whole muscle fibers were involved in the single twitch experiments for the neuromus cular blocking action whereas only the super ficial fibers were used in the microelectrode study. An additional synergism may be pro vided by the inhibitory effect of nicardipine on the hydrolysis of SCh, which takes place during its diffusion into the deep muscle layers. Indeed, neostigmine at 1 nM, which in hibited the enzyme to the same extent as 10 i M nicardipine, reduced the IC5O of SCh 2 fold for the blocking of twitch responses. 495-499 (1988) 
